| abstract |
N-(6-((2R,3S)-3,4-DI-HYDROXYBUTAN-2-YLOXY)-2-(4-FLUOROBENZYLTIO)PYRIMIDIN-4-YL)-3-METHYLAZETIDINE-1-SULFONAMIDE AS A RECEPTOR MODULATOR OF CHEMOKINE. The present invention relates to a compound which is (a) a pyrimidine sulfonamide of formula (I) or (b) a pharmaceutically acceptable salt thereof, crystalline forms of the compound, process for obtaining the compound, pharmaceutical intermediates used in the manufacture of the compound. compound, and pharmaceutical compositions containing the compound. The compound is useful in the treatment of a disease/condition in which modulation of chemokine receptor activity is beneficial. |